Archive for November, 2008

A New Test to Detect Osteoarthritis Early… Will it Help?

Friday, November 28th, 2008

Osteoarthritis is the most common form of arthritis. It affects more than 20 million Americans according to some estimates. Because osteoarthritis (OA) is primarily a degenerative process, the incidence and prevalence of this disorder is expected to rise with the surge in Baby Boomers.

OA affects weight-bearing joints such as the knee and hip. It is a d…

Arthritis Medications - What Are Your Options?

Sunday, November 23rd, 2008

Arthritis is a painful and debilitating disease with more than
100 prescription drugs available for treatment. So which
arthritis medications are right for you? Know your options.
Prescription medications are a treatment option that is often
used to treat arthritis. There are always potential side
effects that can occur and you need to be aware of what
these side effects are so always check with…

FDA Panel Members: All Arthritis Drugs Suspect

Sunday, November 16th, 2008

Feb. 17, 2005 - All of the arthritis drugs in the family that includes Vioxx appear to raise the risk of heart attacks and strokes, several members of an FDA panel suggested Wednesday.
Late in a second day of an FDA inquiry into the safety of the drugs, experts appeared to lean heavily toward the conclusion that safety concerns that drove Vioxx from the market in September apply to other similar drugs, known collectively as Cox-2 inhibitors. Several suggested that incre…

Drug Store News - Arthritis Rx moves toward OTC aisles

Monday, November 10th, 2008

Arthritis now affects 1-in-every-6 Americans, making it one of the most widespread diseases in the United States. In total there are 46 million doctor-diagnosed cases, and experts predict that count to rise to 67 million by 2020.
In a recent study by the Centers for Disease Control, cases were expected to rise in all but two states and the D…

Business Wire - Research and Markets: Celebrex Will Remain the Market Leading Brand for Osteoarthritis Treatment until Patent Expiry in 2014, When More Than 70% First Year…

Monday, November 3rd, 2008

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/0d0629/forecast_insight) has announced the addition of the “Forecast Insight: Osteoarthritis” report to their offering.
Introduction
With several recent non-approvable decisions in the osteoarthritis market since 2006, We have updated its forecast to account for the effect on the market. We have revised the marke…